Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1981 2019

Clinical Trials
Radiation Oncology
Translational Medical Research
Health Services Research
Genomics
Breast Neoplasms
Epidemiology
Population
Neoplasms
Genomic Instability
Hormones
Breast Neoplasms
Recurrence
Neoplasms

Research Output 1989 2017

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

Freedman, R. A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J. & Muss, H. B. Jan 1 2017 In : Breast Cancer Research and Treatment. 161, 2, p. 363-373 11 p.

Research output: Contribution to journalArticle

Anthracyclines
Myelodysplastic Syndromes
Adjuvant Chemotherapy
Acute Myeloid Leukemia
Breast Neoplasms
176 Citations

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer

Tolaney, S. M., Barry, W. T., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M., Shapira, I., Wolff, A. C., Carey, L. A., Overmoyer, B. A., Partridge, A. H., Guo, H., Hudis, C. A., Krop, I. E., Burstein, H. J. & Winer, E. P. Jan 8 2015 In : New England Journal of Medicine. 372, 2, p. 134-141 8 p.

Research output: Contribution to journalArticle

Paclitaxel
Breast Neoplasms
Confidence Intervals
Disease-Free Survival
Recurrence
1 Citations

CCR 20th anniversary commentary: Simpson's paradox and neoadjuvant trials

Carey, L. A. Sep 15 2015 In : Clinical Cancer Research. 21, 18, p. 4027-4029 3 p.

Research output: Contribution to journalReview article

Anniversaries and Special Events
Neoadjuvant Therapy
Research
Neoplasms
Biomarkers
8 Citations

Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)

Ruddy, K. J., Guo, H., Barry, W., Dang, C. T., Yardley, D. A., Moy, B., Marcom, P. K., Albain, K. S., Rugo, H. S., Ellis, M. J., Shapira, I., Wolff, A. C., Carey, L. A., Overmoyer, B. A., Hudis, C., Krop, I. E., Burstein, H. J., Winer, E. P., Partridge, A. H. & Tolaney, S. M. Jun 4 2015 In : Breast Cancer Research and Treatment. 151, 3, p. 589-596 8 p.

Research output: Contribution to journalArticle

Amenorrhea
Paclitaxel
Drug Therapy
Breast Neoplasms
Alkylating Agents
16 Citations

Circulating tumor cell analysis in metastatic triple-negative breast cancers

Magbanua, M. J. M., Carey, L. A., DeLuca, A., Hwang, J., Scott, J. H., Rimawi, M. F., Mayer, E. L., Marcom, P. K., Liu, M. C., Esteva, F. J., Park, J. W. & Rugo, H. S. Mar 1 2015 In : Clinical Cancer Research. 21, 5, p. 1098-1105 8 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Circulating Neoplastic Cells
Cell Count
Metagenomics
Phase II Clinical Trials